NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS STOCK EXCHANGE ANNOUNCEMENT. Oslo, Norway – 31 March 2025 - Reference is made to the stock exchange announcements from IDEX Biometrics ASA (the "Compan ...

IDEX Biometrics ASA will hold an extraordinary general meeting (“EGM”) on Friday 11 April 2025 at 12.00 CET as an online meeting.  Reference is made to the announcement by IDEX Biometrics ASA (the "Company") on 11 March 2025 regarding the loan financing of NOK 30 million secured, proposed debt conversion, and amendment of Convertible Bond. The EGM-notice and the interim statement of financial position are attached. Shareholders may attend online by PC, smartphone or tablet. There is no physical attendance o ...

IDEX Corporation (IEX) is poised to benefit from strength in the Fluid & Metering Technologies segment. Strong momentum in the intelligent water business, driven by continued strength in the North American municipal market and rising governmental funding to support ongoing investments, bodes well for the segment. The segment’s organic revenues increased 3% on a year-over-year basis in the fourth quarter of 2024. The company expects overall organic revenues to increase 1-3% year over year in 2025.The company ...

Group 1 - IDEX Biometrics has received a production order valued at approximately USD 50,000 from Beautiful Card Corporation for a biometric payment card program in the Japanese market [1] - Beautiful Card Corporation is positioned as a leader in the biometric smart card sector, focusing on payment and access cards globally [2] - IDEX Biometrics specializes in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity, leveraging patented technologies [3] Group 2 - The announcement was made in compliance with the EU Market Abuse Regulation and the Norwegian Securities Trading Act [5]

Core Viewpoint - IDEX Biometrics ASA has announced the commencement of the exercise period for Warrants A, allowing holders to subscribe for new shares at a price of NOK 0.15, with the exercise period running from 28 February 2025 to 13 March 2025 [2][3]. Company Information - IDEX Biometrics ASA is a global technology leader in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity [6]. - The company's biometric solutions are built on patented sensor technologies and target card-based applications for payments and digital authentication [6]. - IDEX Biometrics partners with leading card manufacturers and technology companies to bring its solutions to market [6]. Warrant Details - Each Warrant A allows the holder to subscribe for one new share at a subscription price of NOK 0.15, with unexercised Warrants A lapsing without compensation [3]. - The exercise procedure requires the submission of a completed exercise form and payment of the aggregate subscription price for the new shares [4]. - Warrants B will have a separate exercise period from 31 March 2025 to 11 April 2025 [3].

Financial Performance - For the year ended December 31, 2024, Fluid & Metering Technologies (FMT) contributed 38% to net sales and 42% to Adjusted EBITDA, consistent with 2023 figures[18]. - Health & Science Technologies (HST) accounted for 39% of net sales and 36% of Adjusted EBITDA in 2024, compared to 40% and 37% respectively in 2023[18]. - Fire & Safety/Diversified Products (FSDP) represented 23% of net sales and 22% of Adjusted EBITDA in 2024, slightly up from 22% and 21% in 2023[18]. - In 2024, the company reported net sales of $3,268.8 million, flat overall and down 2% organically compared to 2023[145]. - Diluted earnings per share (EPS) attributable to the company were $6.64, down 15% from $7.85 in 2023[148]. - Adjusted EBITDA for 2024 was reported at $874.3 million, compared to $899.6 million in 2023, indicating a decrease in operational performance[195]. - Adjusted net income attributable to IDEX for 2024 was $598.5 million, a decrease from $623.6 million in 2023[194]. - The net income margin for 2024 was 15.4%, compared to 18.2% in 2023, reflecting a decline in profitability[195]. Acquisitions and Growth Strategy - The company acquired Mott Corporation in September 2024, enhancing its capabilities in fluidic applications across various markets[30]. - The company aims to continue developing new products to drive organic growth, as failure to do so could limit sales growth[77]. - The growth strategy includes acquisitions to expand into new markets and enhance positions in existing markets[78]. - The acquisition of Mott Corporation occurred within the twelve months ended December 31, 2024, contributing approximately 8% to total assets and 2% to net sales of the consolidated financial statements[210]. Operational Efficiency and Corporate Strategy - IDEX's diverse business segments focus on organic growth, strategic acquisitions, and capital allocation priorities to improve operational efficiency[16]. - The company emphasizes the importance of its reporting units as leaders in their respective markets, contributing to strong financial performance[19]. - IDEX maintains a philosophy of "The IDEX Difference," focusing on customer service and operational excellence across its subsidiaries[15]. Employee Engagement and Workforce - The company reported a stable employee engagement index of 81%, which is above the manufacturing industry average, reflecting a positive work environment[58]. - Approximately 4% of the company's 9,000 employees are covered by collective bargaining agreements, with no agreements expiring in 2025, suggesting stable labor relations[51]. - 78% of employees feel a strong sense of belonging according to the 2024 employee engagement survey[61]. - The company invests in employee development, offering a Tuition Reimbursement program that covers up to $5,250 per year for eligible U.S. employees[56]. - The company maintains a diverse workforce, with a focus on fostering a culture of inclusion and innovation, which is foundational to its business strategy[59]. - The company offers competitive pay and benefits, including performance-based pay packages and equity-based long-term incentives for senior leaders[62]. Financial Position and Capital Management - The Company maintains a Credit Agreement with a revolving credit facility of $800 million, which may be adversely affected by significant increases in interest rates[102]. - The company maintained a current ratio of 2.5 to 1 and had cash and cash equivalents of $620.8 million as of December 31, 2024[166]. - The company was in compliance with financial covenants, with an interest coverage ratio of 16.09 to 1 and a leverage ratio of 2.20 to 1[178]. - The quarterly cash dividend increased by 8% from $0.64 to $0.69 per share, with total dividend payments rising to $205.3 million in 2024[177]. Risks and Challenges - The company faces risks related to competition, which could reduce sales and profit margins[81]. - The availability and pricing of raw materials and components are critical, with potential adverse effects on financial condition[82]. - Cybersecurity threats and data privacy laws are increasing, requiring the company to strengthen compliance and information security measures[84]. - The company has experienced a rise in cyberattacks targeting confidential business information, particularly in the manufacturing industry[85]. - Increased public awareness regarding environmental risks may lead to new regulations that could increase the Company's expenses and adversely affect its operating results[90]. - The Company faces risks related to catastrophic weather events and public health threats, which could disrupt operations and negatively impact financial results[95][96]. - The unpredictability of cybersecurity risks may result in material adverse effects on the Company's financial condition[87]. - The Company may face legal and regulatory challenges related to intellectual property, which could adversely impact its competitive position and financial condition[106]. Internal Controls and Reporting - Internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting[213]. - The company's management is responsible for maintaining effective internal control over financial reporting[211]. - Limitations exist in internal control over financial reporting, which may not prevent or detect misstatements[214]. - The audit report expressed an unqualified opinion on the financial statements for the year ended December 31, 2024[209].

Core Insights - BAE Systems' Amphibious Combat Vehicle (ACV) is debuting at the International Defence Exhibition and Conference (IDEX) 2025 in the UAE, marking a significant step towards international expansion [1][2] - The ACV is designed for versatility in rugged terrains, enhancing operational effectiveness for military forces globally [2] - The vehicle is currently in full-rate production in the U.S. and is tailored to meet the unique requirements of modern expeditionary warfare [4] Product Features - The ACV is an 8x8 platform that combines open-ocean amphibious capability with land mobility, suitable for various military mission roles [2] - The ACV family includes four variants: ACV-P (Personnel), ACV-C (Command), ACV-30mm (armed variant), and ACV-R (Recovery) [3][6] - The ACV enhances Humanitarian Assistance Disaster Relief efforts by navigating challenging environments to deliver supplies and personnel [3] Strategic Partnerships - BAE Systems has leveraged its partnership with the U.S. Marine Corps to design the ACV, ensuring it meets modern warfare requirements [2] - The collaboration with Iveco Defence Vehicles contributes to the ACV's multi-purpose armored vehicle capabilities [2]

Core Viewpoint - Goodbridge Capital Corp. is proceeding with a private placement offering of up to 10 million subscription receipts at a price of $0.50 each, aiming for gross proceeds of up to $5 million, in connection with a proposed reverse take-over transaction with IDEX Metals Corp. [1][2] Group 1: Offering Details - The offering is part of a reverse take-over transaction where Goodbridge will acquire 100% of IDEX's Class A common shares through an amalgamation agreement [2] - Each subscription receipt will convert into an IDEX unit, which includes one IDEX share and half of an IDEX share purchase warrant, upon satisfaction of escrow release conditions [3] - The offering may also include an over-allotment option allowing the Co-Lead Agents to sell up to an additional 15% in subscription units [4] Group 2: Financial Terms - IDEX will pay the Agents a fee of up to 7.0% of the gross proceeds from the sale of subscription receipts, along with broker warrants equal to up to 7.0% of the total subscription receipts issued [5] - The net proceeds from the offering are intended for work programs related to IDEX's Freeze Project and Amie Project, as well as for working capital [7] Group 3: Regulatory and Closing Information - The offering is expected to close on or about March 4, 2025, subject to necessary regulatory and corporate approvals [8] - Proceeds from the offering will be held in escrow until all conditions are met, with a return of funds to subscription receipt holders if conditions are not satisfied within 60 days post-closing [9] Group 4: Company Background - IDEX Metals Corp. focuses on exploring high-value mineral assets in Idaho, with 15 exploration properties targeting base and precious metals [11] - Goodbridge Capital Corp. is designated as a Capital Pool Company and aims to identify and evaluate businesses for a qualifying transaction [12]

Core Insights - IDEX Corporation's fourth-quarter 2024 adjusted earnings were $2.04 per share, exceeding the Zacks Consensus Estimate of $2.03, marking an 11% increase from $1.83 per share in the same quarter last year [1] - For the full year, adjusted earnings were reported at $7.89 per share, reflecting a 4% decline year over year [1] Revenue Details - IDEX's net sales for the fourth quarter were $863 million, slightly below the Zacks Consensus Estimate of $865 million, but up 9% year over year [2] - Organic sales increased by 3% year over year, while acquisitions/divestitures contributed positively to sales by 6% [2] - For the full year 2024, net revenues were reported at $3.3 billion, remaining flat compared to the previous year [2] - The Fluid & Metering Technologies segment reported net sales of $299.3 million, flat year over year, with organic sales up 3% [2] - The Health & Science Technologies segment saw net sales of $373.2 million, a 19% increase year over year, while organic sales remained flat [3] - The Fire & Safety/Diversified Products segment reported net sales of $192.9 million, an 8% increase year over year, with organic sales also up 8% [3] Margin Profile - IDEX's cost of sales increased by 9.7% year over year to $495.8 million, with gross profit rising 9% to $367.1 million [4] - The gross margin was reported at 42.5%, slightly down from 42.7% in the previous year [4] - Selling, general and administrative expenses rose by 10.3% year over year to $197.9 million [4] - Adjusted EBITDA increased by 11.7% year over year to $227.5 million, with an adjusted EBITDA margin of 26.4%, up 60 basis points [4] - Operating income was $165.3 million, a 3% increase year over year, with an operating margin of 19.2%, down 110 basis points [5] Balance Sheet and Cash Flow - At the end of the fourth quarter, IDEX had cash and cash equivalents of $620.8 million, up from $534.3 million a year earlier [6] - Long-term borrowings increased to $1.9 billion from $1.33 billion at the end of the previous year [6] - In 2024, IDEX generated net cash from operating activities of $668.1 million, down 6.8% year over year [7] - Capital expenditures were reported at $65.1 million, a decrease from $89.9 million in 2024 [7] - Free cash flow was $603 million, down 3.8% year over year, while dividends paid totaled $205.3 million, up 7.7% year over year [7] Outlook - For the first quarter of 2025, IDEX anticipates adjusted earnings in the range of $1.18-$1.24 per share, with organic sales expected to decrease by 3-4% [9] - For the full year 2025, adjusted earnings are projected to be between $8.10-$8.45 per share, indicating an increase from $7.89 per share in 2024 [10] - Organic sales for 2025 are expected to grow in the range of 1-3% [10]

Financial Data and Key Metrics Changes - Fourth quarter orders reached $817 million, an increase of approximately 8% on a reported basis and 5% organically [29] - Fourth quarter sales were $863 million, up 9% reported and 3% organically compared to the prior year [31] - Full year sales totaled $3.3 billion, flat overall and down 2% organically [33] - Fourth quarter net income was $123 million, resulting in GAAP diluted EPS of $1.62, while adjusted net income was $155 million with an adjusted EPS of $2.04 [38] - Free cash flow for the quarter was $157 million, a decrease of 12%, with a full year free cash flow of $603 million, down 4% versus last year [39] Business Line Data and Key Metrics Changes - Health and Science Technology (HST) segment experienced 8% organic growth in Q4, driven by blanket order activity [29] - Fire Safety and Diversified Products (FSDP) had mid-single-digit organic growth, while Flow Measurement Technologies (FMT) experienced low single-digit growth [29] - HST contracted by 7% on an organic basis for the full year, driven by life sciences and semiconductor cyclical market headwinds [34] - FSDP drove low single-digit growth, bolstered by North America Fire OEM and integrated system solution demand [34] Market Data and Key Metrics Changes - The company noted a stable business base with inventories and lead times recalibrated back to normal levels as it enters 2025 [13] - The outlook for 2025 includes organic growth of 1% to 3%, with HST expected to be the highest growth segment [45] - The company anticipates a modest lift in life sciences and optical filters, alongside a second-half recovery in semiconductor capital equipment [46] Company Strategy and Development Direction - The company is focused on integrating Mott and leveraging its filtration technologies into new innovative solutions [26] - A strategic roadmap emphasizes collaboration across business units to drive growth and earnings expansion [17] - The company continues to apply the 80/20 principle at the enterprise level to enhance productivity and focus on high-quality businesses [15] Management's Comments on Operating Environment and Future Outlook - Management expressed a climate of uncertain optimism as macroeconomic conditions stabilize, with geopolitical tensions remaining a concern [13] - The company is committed to outperforming throughout the economic cycle, leveraging differentiated technologies to address complex problems [14] - Management highlighted the importance of customer intimacy and pricing power in driving above-market growth [44] Other Important Information - The company plans to take $21 to $25 million in restructuring charges during 2025, primarily related to severance [53] - The effective tax rate for 2025 is projected to be approximately 22% to 23%, reflecting a heavier mix of improved performance in regions with higher tax rates [55] Q&A Session Summary Question: Why is Q1 expected to be soft, and what gives confidence in the remaining part of the year? - Management explained that Q1 softness is due to $40 million of project shipments in Q4 not repeating and a $0.20 headwind from share-based compensation [76][77] - Confidence in HST orders comes from strong blanket order activity tied to life sciences and semiconductor businesses [80] Question: What does platform optimization and delayering mean for growth and margins? - Management indicated that moving top-line growth while optimizing costs will enhance both gross margins and EBITDA margins over time [125][126] Question: What assumptions are made regarding potential tariff impacts? - Management stated that there are no material assumptions in the guidance regarding tariffs, emphasizing a localized sourcing model to mitigate risks [102][106] Question: What is the mix of proprietary versus competitive targets in the M&A funnel? - Management noted a focus on proprietary transactions, aiming to maintain an 80% proprietary level in future deals [110][112]